News

The EXIAS e|1 Analyzer is an electrolyte system intended for in-vitro measurements of Na+, K+, Cl-, Ca2+ as well as pH and Hct, in whole blood, serum, plasma and urine (undiluted). High accuracy, ease of use and the maintenance free …

The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in < 7 minutes …

The LumiraDx NT-proBNP test is the only quantitative direct fingerstick NT-proBNP test available today*. An easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP levels in whole blood and plasma, the LumiraDx NT-proBNP test delivers reliable, quantitative results …

Simple, accurate test – the solution you need when time matters Current testing options for NPM1 are not only cumbersome, but also expensive and time consuming for the lab to implement. The Xpert NPM1 Mutation test* eliminates the need for …

The Xpert® BCR-ABL Ultra p190 test is an automated test for quantifying the amount of BCR-ABL1 p190 transcript as a ratio of BCR-ABL p190/ABL1 with high sensitivity. Using the innovative GeneXpert® system technology, the Xpert BCR-ABL Ultra p190 test automates …

With the current rise in flu cases and possible spread of emerging respiratory viruses, like the novel coronavirus (COVID-19), laboratories and healthcare providers can expect another very busy flu season. The  2019-2020 flu season is on track to be one …

Cepheid received Emergency Use Authorization from the U.S. FDA for its next-generation test to support the global fight against COVID-19 during the upcoming respiratory virus season. The test can provide rapid detection of the current coronavirus SARS-CoV-2 in as soon …